Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Genealogy Testing Service Relies on High-Throughput Microarray Technology

By LabMedica International staff writers
Posted on 19 May 2010
An advanced genotyping system is the basis for a new genealogic testing service that can match a wide range of family relationships within five generations. More...


Family Tree DNA (Houston, TX, USA), the first company to develop the commercial application of DNA testing for genealogical purposes, has launched a new genotyping service (The Family Finder) that will allow individuals, regardless of gender, to explore linkages to grandparents, aunts and uncles, half siblings, and first, second, third, and fourth cousins.

The test is based on Affymetrix (Santa Clara, CA, USA) Axiom genotyping technology and the associated GeneTitan analytical system. With the Axiom test, total genomic DNA (200 ng) is amplified and randomly fragmented into 25-125 base pair fragments. These fragments are purified, resuspended, and hybridized to Axiom Genome-wide human array plates. Following hybridization, the bound target is washed under stringent conditions to remove nonspecific background to minimize background noise caused by random ligation events. Each polymorphic nucleotide is queried via a multicolor ligation event carried out on the array surface. After ligation, the arrays are stained and imaged on the GeneTitan Instrument. The imaging device in the GeneTitan Instrument uses an external, high-intensity xenon lamp and dual excitation and emission filters to capture images from array plates.

The Family Finder test analyzes the DNA of two individuals using Axiom array plates containing nearly 570,000 genetic markers, including many that are relevant to genealogy. The assay system utilizes the complete Axiom genotyping solution, which includes array plates, complete reagent kits, and an automated workflow that enables scientists to process more than 760 samples per week. Family Tree DNA then analyzes the resulting data with internally developed algorithms to determine the closeness of the relationship.

"This is the most exciting genetic genealogy breakthrough since 2000, when Family Tree DNA launched its Y-DNA test to uncover relatives in the direct paternal line,” said Bennett Greenspan, CEO of Family Tree DNA. "The comprehensive, genome-wide coverage of Axiom Arrays enables us to offer consumers the most advanced genealogical test available at a price that is attractive to our customers. In addition, the automated GeneTitan system allows us to process hundreds of samples at a time with minimal hands-on time for maximum efficiency.”

"The Family Finder test represents a huge step forward for the direct-to-consumer genetic genealogy market and the application of microarray technology,” said Kevin King, CEO of Affymetrix. "Now anyone can utilize the power of the Axiom genotyping solution and the GeneTitan System to find and connect with a broader range of family members than ever before.”

Related Links:

Family Tree DNA
Affymetrix



Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
Gold Member
Collection and Transport System
PurSafe Plus®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.